Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease

Gynecologic Oncology
R E BristowF J Montz

Abstract

The aim of this study was to evaluate survival outcome in patients with locoregional uterine papillary serous carcinoma (UPSC) after extended surgical staging (ESS). All patients diagnosed with FIGO Stage I-III UPSC undergoing ESS (vertical incision, peritoneal cytology, TAH/BSO, omental biopsy, lymph node sampling, peritoneal biopsy) between 1/1/89 and 12/31/98 were identified retrospectively from the tumor registry database. Pathologic features predictive of regional extrauterine spread were evaluated using the log-rank test. The Kaplan-Meier method was used to generate survival curves, and median survival determinations were compared using the log-rank test or the proportional hazards regression model. Twenty-six patients with locoregional UPSC were identified: FIGO Stage I (n = 11), Stage II (n = 7), and Stage III (n = 8). The median age at diagnosis was 66 years. Preoperative endometrial pathology correctly identified the presence of UPSC in 76.9% of cases. The only pathologic feature found to be predictive of regional extrauterine spread (Stage III) was myometrial invasion > or =50% (P = 0.028). Adjuvant radiation therapy (RT) was administered to 6/18 patients with Stage I/II disease and 5/8 patients with Stage III diseas...Continue Reading

References

Jun 1, 1992·The American Journal of Surgical Pathology·M E ShermanR J Kurman
Sep 1, 1991·International Journal of Radiation Oncology, Biology, Physics·S GibbonsG Malkasian
Dec 1, 1990·Gynecologic Oncology·B G WardK Free
Jun 1, 1989·Cancer·H H GallionK Nelson
Jan 1, 1987·Obstetrics and Gynecology·J T ChambersP E Schwartz
May 1, 1986·Obstetrics and Gynecology·J F JeffreyR J Lotocki
May 1, 1995·Cancer·G GitschN F Hacker
Jul 1, 1996·Gynecologic Oncology·E Resnik, J B Taxy
Sep 1, 1996·Clinical Obstetrics and Gynecology·J L Nicklin, L J Copeland
Jan 9, 1998·International Journal of Radiation Oncology, Biology, Physics·B C TurnerL D Wilson
Jun 8, 2000·The American Journal of Surgical Pathology·D T WheelerM E Sherman
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·E. H. Tay, B. G. Ward

❮ Previous
Next ❯

Citations

Oct 27, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Karuna GargRobert A Soslow
Mar 27, 2003·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·P A GehrigW C Fowler
Jun 29, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·D FaratianH Monaghan
Sep 16, 2011·ISRN Obstetrics and Gynecology·Laurie ElitWaldo Jimenez
Aug 17, 2002·International Journal of Radiation Oncology, Biology, Physics·Kaled M AlektiarRichard R Barakat
Aug 12, 2003·International Journal of Radiation Oncology, Biology, Physics·Brij M SoodB Vikram
Dec 17, 2003·Gynecologic Oncology·Brian M SlomovitzKaren H Lu
Feb 22, 2003·Current Treatment Options in Oncology·Felice D Lackman, Peter S Craighead
Mar 7, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A P VaidyaL R Duska
Mar 7, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·H SteedA M Oza
Sep 26, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·J S KwonM S Carey
Oct 4, 2005·International Journal of Radiation Oncology, Biology, Physics·Chad A HamiltonJohn K Chan
Oct 27, 2012·Archives of Gynecology and Obstetrics·Giovanna ScarfoneGiorgio Bolis
Nov 26, 2013·Clinics in Laboratory Medicine·Quratulain AhmedRouba Ali-Fehmi
Aug 10, 2010·Gynecologic Oncology·J Alejandro Rauh-HainMarcela G del Carmen
Jan 30, 2010·Gynecologic Oncology·Monica Prasad Hayes, Lora Hedrick Ellenson
Mar 11, 2009·Gynecologic Oncology·Monica Prasad HayesLora Hedrick Ellenson
Jul 23, 2008·Gynecologic Oncology·Alexander B OlawaiyeMarcela G del Carmen
Jul 26, 2012·BJOG : an International Journal of Obstetrics and Gynaecology·H MahdiA R Munkarah
Jul 28, 2004·International Journal of Radiation Oncology, Biology, Physics·Janice KwonEdmee Franssen
Aug 29, 2006·Gynecologic Oncology·Dimitry L LernerAndrew J Li
Aug 21, 2009·Gynecologic Oncology·Nana E TchaboWainwright Jaggernauth
Apr 12, 2007·Expert Opinion on Pharmacotherapy·Paola A Gehrig
May 2, 2006·American Journal of Obstetrics and Gynecology·Alessandro D SantinSergio Pecorelli
Sep 25, 2012·Gynecologic Oncology·Marcela G del CarmenJohn O Schorge
Dec 3, 2005·The Lancet Oncology·Sheetal AcharyaGini F Fleming
Jul 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gini F Fleming
Jan 10, 2017·Journal of Minimally Invasive Gynecology·Giorgia MonterossiFrancesco Fanfani
Jun 19, 2009·British Journal of Cancer·E CoccoA D Santin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.